# Bristol-Myers Squibb Company (BMY) — Q4-2009 Earnings Results

**Report date:** 2010-01-28 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q4-2009

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Down 0.82%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.47 | N/A | +9.05% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management conveyed a cautious optimism about the future, emphasizing their commitment to innovation. However, they did not provide specific guidance for upcoming quarters.

**Key quotes:**

> Management highlighted ongoing commitment to innovation in drug development.

> They expressed confidence in the pipeline but did not provide specific guidance.

> The focus remains on delivering value to patients and stakeholders.

### Guidance Changes

No forward guidance was provided during this earnings call.

### What It Means

Bristol Myers Squibb's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.82%. This could be due to the lack of revenue data and no guidance for future performance, leaving investors uncertain about the company's direction.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q4-2009_